Kupweteka kwa Supartz kwa Knee Osteoarthritis

Hivuronate Yavomerezedwa Yogwiritsidwa Ntchito ku Viscosulementlementation

Supartz, yankho la sodium hyaluronate, ndi imodzi mwa hyaluronates yomwe imagwiritsidwa ntchito pa viscosupplementation . Supartz imayikidwa mwachindunji kumapeto kwa bondo pofuna kubwezeretsa malo osungira ndi odzola a synovial fluid (mwachitsanzo, kuphatikiza madzi). Sodium hyaluronate yomwe imagwiritsidwa ntchito ku Supartz imachokera ku nkhuku zowakomera. Sodium hyaluronate ndi polysaccharide yomwe imaphatikizapo magawo osakaniza a glucuronic acid ndi N-acetylglucosamine .

Kuvomereza kwa Supartz ndi Supartz Fx

Supartz inavomerezedwa ndi US FDA pa January 24, 2001 kuti athetse chithandizo cha knee osteoarthritis kwa odwala omwe sanathe kupeza chithandizo chokwanira ndi mankhwala osamalitsa, kuphatikizapo kuchita masewera olimbitsa thupi, mankhwala opatsirana, mankhwala opweteka , zipangizo zothandizira , komanso mapepala otentha kapena ozizira . Kugwiritsa ntchito ziwalo zina mukufufuzidwa. Supartz imagwiritsidwa ntchito ku Japan kuyambira 1987. Imayikidwa kamodzi pa sabata kwa mlungu wa milungu isanu. Odwala ena angayankhe bwino patatha masabata atatu.

Pa October 12, 2015, Bioventus, wopanga Supartz, adalengeza kuti Supartz Fx (10 mg sodium hyaluronate inathetsedwa mu 1.0% ya saline), yomwe ili ndi chizindikiro choonjezera cha Supartz choyambirira, chomwe chimayambitsanso kulandira jekeseni. Ngakhale kuti chizindikiro cha chitetezo chinawonjezeka kuti chilowetsedwe mobwerezabwereza, mphamvu ya kubwereza nthawi siinakhazikitsidwe.

Chenjezo ndi Kusamala

Supartz sayenera kuperekedwa kwa wodwalayo aliyense ndi hypersensitivity odziwika kuti mankhwala a sodium hyaluronate.

Chenjezo liyenera kugwiritsidwa ntchito pochiza odwala omwe amadziwika bwino ndi mapuloteni, mazira, kapena nthenga. Odwala omwe ali ndi kachilombo kapena matenda a khungu pamalo omwe jekeseni amaperekedwa sayenera kuchitidwa ndi Supartz.

Supartz oteteza komanso ogwira ntchito sizinakhazikitsidwe mwa amayi apakati, ngakhalenso akazi operewera.

Ntchito yake siinaphunzirepo kwa ana.

Zotsatira Zogwirizana

Zotsatira zoyipa kapena zovuta zomwe Supartz amachita zikuphatikizapo:

Kutupa kapena kupweteka, komwe kumakhala kochepa, kungathe kuchitika mu mgwirizano umene wajambulidwa ndi Supartz. Odwala amalangizidwa kupewa ntchito zovuta kapena zolemetsa maola 48 pambuyo pa jekeseni.

Mfundo Yofunika Kwambiri

Kuwunika kwa mayesero asanu okonzedweratu owonetsetsa bwino sanawulule kusiyana kwakukulu pakati pa Supartz ndi magulu olamulira pa zochitika zovuta. Ngakhale chitetezo cha Supartz ndi ma viscosupplements ena athandizidwa ndi maphunziro a zachipatala, zakhala zikukambirana bwino. Poganizira za momwe ntchitoyi ikuyendera bwino, Cochrane Review inanenanso kuti njira zowonongeka zogwira ntchito ndizosavuta kuposa placebo, koma panali maphunziro ena omwe sanagwiritse ntchito posonyeza kuti majekeseni amapereka mpumulo waukulu.

Zotsatira:

Supartz Fx. Kufotokozera Information. Bioventus. http://www.supartzfx.com/wp-content/uploads/2015/07/SUPARTZ_FX_Package_Insert.pdf

Bioventus Yayambitsa Supartz Fx Tsopano Ndi Zowonjezera Zowonjezera Zomwe Zidzakhala Zomwe Zimabweretsanso Zomwe Zili M'kati mwa Knee Osteoarthritis. October 12, 2015.
http://www.bioventusglobal.com/news/press-releases/bioventus-launches-supartz-fx%E2%84%A2-now-expanded-safety-label-repeat-injection-cycles

Hyaluronic acid (Supartz): ndemanga ya ntchito yake mu osteoarthritis ya bondo. Curan MP. Mankhwala ndi Kukalamba. November 2010.
http://www.ncbi.nlm.nih.gov/pubmed/20964466